Capital Ltd. Corvus serves as Executive at CONDUIT PHARMACEUTICALS INC., where they oversee executive responsibilities. Since joining the company, Capital Ltd. Corvus has executed 13 insider transactions totaling $4.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 8, 2025 involved receiving (via award) 224,800 shares valued at $402.4K.
Capital Ltd. Corvus currently holds 227,304 shares of CONDUIT PHARMACEUTICALS INC. (CDT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Ltd. Corvus has been a net seller of CDT stock. They have purchased $0 and sold $4.6M worth of shares.
Capital Ltd. Corvus's most recent insider trade was on Dec 8, 2025, when they sold 224,800 shares at $1.79 per share.
Get notified when new Form 4 filings are submitted
| $0.26 |
| Discretionary |
| Jul 16, 2024 | CDT | $3.3M | Sale | 10,244,392 | $0.32 | Discretionary |
| Jul 15, 2024 | CDT | $251.3K | Sale | 1,005,200 | $0.25 | Discretionary |
| Jul 12, 2024 | CDT | $347.5K | Sale | 1,389,820 | $0.25 | Discretionary |
| Jul 11, 2024 | CDT | $87.0K | Sale | 300,000 | $0.29 | Discretionary |
| Jul 11, 2024 | CDT | $174.9K | Sale | 582,952 | $0.30 | Discretionary |
| Jul 10, 2024 | CDT | $49.5K | Sale | 150,000 | $0.33 | Discretionary |
| Jul 9, 2024 | CDT | $34.2K | Sale | 77,681 | $0.44 | Discretionary |
| Jul 8, 2024 | CDT | $18.3K | Sale | 35,923 | $0.51 | Discretionary |
| Jul 3, 2024 | CDT | $640 | Sale | 1,000 | $0.64 | Discretionary |
| Jun 14, 2024 | CDT | $0 | Other | 1,100,000 | $N/A | Discretionary |
| Jun 14, 2024 | CDT | $0 | Other | 1,100,000 | $N/A | Discretionary |